Merck says Q3 sales jump 12% YoY to $12.4B

Tuesday, 29. October 2019 11:49

American pharmaceutical giant Merck & Co. said on Tuesday that its third-quarter worldwide sales jumped 15% to $12.4 billion compared to the previous year. Meanwhile, the company announced earnings per share were 1% higher year over year at $0.74. On an adjusted basis, EPS surged 27% to $1.51.

Growth in the drugmaker was driven mainly by its oncology and vaccine products, particularly Keytruda and Gardasil.

"We achieved another quarter of strong revenue and earnings growth as we continue to realize the benefits of our sustained investment in research and development and our focus on commercial execution," Chief Executive Kenneth C. Frazier said in a statement.

The earnings report that topped expectations pushed Merck's shares up 1.95% in premarket trading.

Related Links: Merck KGaA
Breaking the News / JC